Fran analyses the unprompted online conversations of healthcare professionals to produce actionable insights for clients. Her background in legal research provides a solid foundation in critical thinking and enables a well rounded approach to her data research.
Fran has a keen interest in netball and is a big follower of the New Zealand domestic netball league. She is also a lover of board games and card games, especially ones that involve shouting!
29.09.2023 | Article
There is a significant cluster of highly conversation-connected cardiology specialists
By Francesca Gan
28.09.2023 | Article
What was the response of eHCPs to WHO’s antibiotic book and how are they combatting AMR?
By Francesca Gan
12.06.2023 | Article
Looking at the corporate reputation of the Top 50 pharma companies over the past year
By Francesca Gan
On-Demand | Webinars
How can pharma support HCPs in tackling medical misinformation online?
By Jamie Doggett and Francesca Gan
31.01.2023 | Article
HCP conversations on Phase 3 trial data for lecanemab for Alzheimers has been shifting
By Francesca Gan
05.01.2023 | Article
The 5 companies mentioned the most by HCPs were Pfizer, Moderna, Johnson & Johnson....
By Francesca Gan
18.12.2022 | Article
In Nov 2022 there was a 22% decrease in HCP pharma mentions from the previous month
By Francesca Gan
14.11.2022 | Article
The FDA granted emergency use of Pfizer and Moderna's bivalent vaccine in children
By Francesca Gan
05.10.2022 | Article
The latest developments in the Top 50 tracker saw GSK jump back amongst the Top 5.
By Francesca Gan and Chawanzi Chintu
05.09.2022 | Article
Discover what healthcare professionals (HCPs) think about pharmaceutical companies
By Francesca Gan and Chawanzi Chintu
18.08.2022 | Article
The NHS has not escaped access and funding issues, and given that it is completely govern...
By Francesca Gan
04.08.2022 | Article
Discover what healthcare professionals (HCPs) think about pharmaceutical companies
By Francesca Gan and Chawanzi Chintu
02.07.2022 | Article
Discover what healthcare professionals (HCPs) think about pharmaceutical companies
By Francesca Gan and Chawanzi Chintu
29.06.2022 | Article
Common issues experienced by sufferers of long covid include, amongst others, fatigue...
By Francesca Gan
06.06.2022 | Article
Conversations continued to revolve around COVID-19 vaccine efficacy with HCPs sharing...
By Francesca Gan and Chawanzi Chintu
05.05.2022 | Article
Notably this month, HCPs celebrated the efficacy of Lilly’s tirzepatide for obesity patients
By Francesca Gan and Chawanzi Chintu
14.04.2022 | Article
This is a big issue as SCD is one of the most prevalent genetic diseases, and thus raises...
By Francesca Gan
13.04.2022 | Article
Conversations still largely revolved around vaccine efficacy, with HCPs sharing various...
By Francesca Gan and Chawanzi Chintu
11.03.2022 | Article
HCPs largely discussed healthcare inequity, comparing the revenue of pharmaceutical...
By Francesca Gan and Chawanzi Chintu
22.02.2022 | Article
What do HCPs think about a fourth COVID vaccine
By Francesca Gan
08.02.2022 | Article
HCPs get political when discussing Regeneron’s COVID-19 treatment
By Francesca Gan and Chawanzi Chintu
11.01.2022 | Article
Discover what healthcare professionals (HCPs) are saying about the Omicron variant
By Francesca Gan and Chawanzi Chintu
22.12.2021 | Article
Discover what HCPs wanted for Christmas in 2021
By Paul Cranston and Francesca Gan
01.12.2021 | Article
Discover what healthcare professionals (HCPs) think about pharmaceutical companies
By Francesca Gan and Chawanzi Chintu
01.10.2021 | Article
Discover which new drug approvals and launches HCPs are talking about
By Francesca Gan and Chawanzi Chintu
